We are live on ! Find out more
INBX

Inhibrx, Inc. Common Stock
INBX

Delisted

INBX was delisted on the 29th of May, 2024.

Back to rankings

66 hedge funds and large institutions have $682M invested in Inhibrx, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 25 increasing their positions, 18 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 4

39% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 18

27% more capital invested

Capital invested by funds: $538M → $682M (+$143M)

8% more funds holding

Funds holding: 61 → 66 (+5)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
66
Holders Change
+5
Holders Change %
+8.2%
% of All Funds
1.16%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
25
Reduced
18
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DGM
Darwin Global Management
Jersey
+$9.65M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$9.13M
3
IC
Ikarian Capital
Texas
+$8.57M
4
PA
Perceptive Advisors
New York
+$6.52M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$5.62M

Top Sellers

Rank Fund Capital Flow
1
FCM
Farallon Capital Management
California
-$15.7M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$11M
3
Millennium Management
Millennium Management
New York
-$8.15M
4
SCM
Soleus Capital Management
Connecticut
-$4.41M
5
TCM
Tybourne Capital Management
Hong Kong
-$2.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
26
Soleus Capital Management
Connecticut
$3.26M -$4.41M -144,810 -60%
Schroder Investment Management Group
27
Schroder Investment Management Group
United Kingdom
$3.09M +$2.82M +92,663 New
Bank of New York Mellon
28
Bank of New York Mellon
New York
$2.87M +$789K +25,935 +43%
Deutsche Bank
29
Deutsche Bank
Germany
$2.35M -$15.8K -520 -0.7%
Invesco
30
Invesco
Georgia
$1.99M +$1.56M +51,357 +604%
Millennium Management
31
Millennium Management
New York
$1.65M -$8.15M -267,767 -84%
PPA
32
Parametric Portfolio Associates
Washington
$1.25M +$87.9K +2,890 +8%
State of Wisconsin Investment Board
33
State of Wisconsin Investment Board
Wisconsin
$1.2M +$30K +986 +3%
BFM
34
Boothbay Fund Management
New York
$973K +$889K +29,218 New
Wells Fargo
35
Wells Fargo
California
$972K +$538K +17,692 +154%
JP Morgan Chase
36
JP Morgan Chase
New York
$813K -$163K -5,370 -18%
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$813K +$74K +2,431 +11%
California State Teachers Retirement System (CalSTRS)
38
California State Teachers Retirement System (CalSTRS)
California
$760K -$477K -15,662 -41%
Swiss National Bank
39
Swiss National Bank
Switzerland
$710K – – –
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$673K -$114K -3,761 -16%
PCP
41
Proficio Capital Partners
Massachusetts
$668K +$1.34K +44 +0.2%
AW
42
Alaethes Wealth
Nevada
$644K – – –
Bank of America
43
Bank of America
North Carolina
$643K +$350K +11,510 +148%
AIG
44
American International Group
New York
$509K -$11.1K -364 -2%
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$505K -$42.6K -1,399 -8%
Jacobs Levy Equity Management
46
Jacobs Levy Equity Management
New Jersey
$443K -$589K -19,373 -59%
Creative Planning
47
Creative Planning
Kansas
$400K – – –
M&T Bank
48
M&T Bank
New York
$386K – – –
MIM
49
MetLife Investment Management
New Jersey
$384K – – –
VOYA Investment Management
50
VOYA Investment Management
Georgia
$372K – – –
1
2
3

INBX Hedge Fund Activity: Q3 2021 in Review

66 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Inhibrx, Inc. Common Stock (INBX) for Q3 2021, worth a combined $682M — up 27% from $538M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new INBX positions and 4 closed out — a net gain of 5 holders — while 25 added to existing stakes and 18 trimmed.

The largest buyer was Darwin Global Management, adding an estimated $9.65M. The largest seller was Farallon Capital Management, exiting entirely with an estimated $15.7M sold.

  • 66 institutional investors held Inhibrx, Inc. Common Stock (INBX) as of Q3 2021, up from 61 in Q2 2021.
  • Funds reported $682M of Inhibrx, Inc. Common Stock stock for Q3 2021, up 27% quarter-over-quarter.
  • 9 funds opened new Inhibrx, Inc. Common Stock positions in Q3 2021 and 4 closed out, a net change of +5 holders.
  • The largest Inhibrx, Inc. Common Stock buyer in Q3 2021 was Darwin Global Management, an estimated $9.65M added.
  • The largest Inhibrx, Inc. Common Stock seller in Q3 2021 was Farallon Capital Management, an estimated $15.7M sold.

Based on aggregated 13F filings for Q3 2021.